Cas 861857-67-2,1-benzyl-4-(3-tert-butylphenyl)-piperidin-4-ol

861857-67-2

Post Buying Request

Basic information

Product Name: 1-benzyl-4-(3-tert-butylphenyl)-piperidin-4-ol
Synonyms: 1-benzyl-4-(3-tert-butylphenyl)-piperidin-4-ol
CAS NO:861857-67-2
Molecular Formula:
Molecular Weight: 323.478
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 1-benzyl-4-(3-tert-butylphenyl)-piperidin-4-ol(CAS DataBase Reference)
NIST Chemistry Reference: 1-benzyl-4-(3-tert-butylphenyl)-piperidin-4-ol(861857-67-2)
EPA Substance Registry System: 1-benzyl-4-(3-tert-butylphenyl)-piperidin-4-ol(861857-67-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 861857-67-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

861857-67-2 Suppliers

Recommended suppliers

861857-67-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 861857-67-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,1,8,5 and 7 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 861857-67:
(8*8)+(7*6)+(6*1)+(5*8)+(4*5)+(3*7)+(2*6)+(1*7)=212
212 % 10 = 2
So 861857-67-2 is a valid CAS Registry Number.

861857-67-2Upstream product

861857-67-2Downstream Products

861857-68-3 N-[1-benzyl-4-(3-tert-butylphenyl)-piperidin-4-yl]-2-chloroacetamide

861857-67-2Relevant academic research and scientific papers

METHODS OF TREATMENT OF AMYLOIDOSIS USING ASPARTYL-PROTEASE INHIBITORS

-

Page/Page column 207-208, (2010/02/13)

The invention relates to acetyl 2-hydroxy-1,3-diaminospirocyclohexanes and derivatives thereof that are useful in treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.

SUBSTITUTED UREA AND CARBAMATE, PHENACYL-2-HYDROXY-3-DIAMINOALKANE, AND BENZAMIDE-2-HYDROXY-3-DIAMINOALKANE ASPARTYL-PROTEASE INHIBITORS

-

Page/Page column 238, (2010/02/14)

The invention relates to acetyl 2-hydroxy-1,3-diaminospirocyclohexanes and derivatives thereof that are useful in treating at least one disease, disorder, and condition associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and condition associated with abnormal deposition of A-beta protein.

SUBSTITUTED HYDROXYETHYLAMINE ASPARTYL PROTEASE INHIBITORS

-

Page/Page column 152-153, (2010/02/14)

The invention relates to novel compounds and also to methods of treating at least one disease, disorder, or condition associated with amyloidosis using such compounds. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.

SUBSTITUTED HYDROXYETHYLAMINE ASPARTYL PROTEASE INHIBITORS

-

Page/Page column 296; 297, (2008/06/13)

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 861857-67-2